Arrhythmias in COVID-19

Summit Pandat; Zhihao Zhu; Stephanie Fuentes-Rojas; Paul Schurmann

doi:10.14797/mdcvj.1039

Arrhythmias in COVID-19

Methodist DeBakey Cardiovascular Journal

Volume 17 (2021): Issue 5

By: Summit Pandat, Zhihao Zhu , Stephanie Fuentes-Rojas and Paul Schurmann

Open Access

|Dec 2021

Azevedo RB, Botelho BG, Hollanda JVG, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021 Jan;35(1):4–11. doi: 10.1038/s41371-020-0387-4
Open DOI Search in Google Scholar Back to article
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061–1069. doi: 10.1001/jama.2020.1585
Open DOI Search in Google Scholar Back to article
Griffin DO, Brennan-Rieder D, Ngo B, et al. The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021 Feb 8;23(1):40–47. doi: 10.24875/AIDSRev.200001261
Open DOI Search in Google Scholar Back to article
Atri D, Siddiqi HK, Lang JP, et al. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies. JACC Basic Transl Sci. 2020 Apr 10;5(5):518–536. doi: 10.1016/j.jacbts.2020.04.002
Open DOI Search in Google Scholar Back to article
Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017 Jun 7;38(22):1717–1727. doi: 10.1093/eurheartj/ehw208
Open DOI Search in Google Scholar Back to article
Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019 Jan;19(1):63–64. doi: 10.1038/s41577-018-0098-z
Open DOI Search in Google Scholar Back to article
Clark RE, Christlieb I, Sanmarco M, Diaz-Perez R, Dammann JF, Zipser ME. Relationship of hypoxia to arrhythmia and cardiac conduction hemorrhage. Circulation. 1963 Apr 1;27:742–747. doi: 10.1161/01.CIR.27.4.742
Open DOI Search in Google Scholar Back to article
Macdonald WA, Hool LC. The effect of acute hypoxia on excitability in the heart and the L-type calcium channel as a therapeutic target. Curr Drug Discov Technol. 2008 Dec;5(4):302–11. doi: 10.2174/157016308786733546
Open DOI Search in Google Scholar Back to article
Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap! Circulation. 2020 Jul 7;142(1):7–9. doi: 10.1161/CIRCULATIONAHA.120.047293
Open DOI Search in Google Scholar Back to article
Kolettis TM. Coronary artery disease and ventricular tachyarrhythmia: pathophysiology and treatment. Curr Opin Pharmacol. 2013 Apr;13(2):210–7. doi: 10.1016/j.coph.2013.01.001
Open DOI Search in Google Scholar Back to article
Gemel J, Su Z, Gileles-Hillel A, Khalyfa A, Gozal D, Beyer EC. Intermittent hypoxia causes NOX2-dependent remodeling of atrial connexins. BMC Cell Biol. 2017 Jan 17;18(Suppl 1):7. doi: 10.1186/s12860-016-0117-5
Open DOI Search in Google Scholar Back to article
Chen C, Chen C, Yan JT, Zhou N, Zhao JP, Wang DW. [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):567–571. doi: 10.3760/cma.j.cn112148-20200225-00123
Open DOI Search in Google Scholar Back to article
Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020 Jul 15;253:117723. doi: 10.1016/j.lfs.2020.117723
Open DOI Search in Google Scholar Back to article
Peretto G, Sala S, Rizzo S, et al. Arrhythmias in myocarditis: State of the art. Heart Rhythm. 2019 May;16(5):793–801. doi: 10.1016/j.hrthm.2018.11.024
Open DOI Search in Google Scholar Back to article
Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Sep 1;5(9):1036–1041. doi: 10.1001/jamacardio.2020.1834
Open DOI Search in Google Scholar Back to article
Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc. 2020 Jun;95(6):1213–1221. doi: 10.1016/j.mayocp.2020.03.024
Open DOI Search in Google Scholar Back to article
Dherange P, Lang J, Qian P, et al. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol. 2020 Sep;6(9):1193–1204. doi: 10.1016/j.jacep.2020.08.002
Open DOI Search in Google Scholar Back to article
Amaratunga EA, Corwin DS, Moran L, Snyder R. Bradycardia in Patients With COVID-19: A Calm Before the Storm? Cureus. 2020 Jun 13;12(6):e8599. doi: 10.7759/cureus.8599
Open DOI Search in Google Scholar Back to article
Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949
Open DOI Search in Google Scholar Back to article
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 Nov 19;383(21):e119. doi: 10.1056/NEJMx200021
Open DOI Search in Google Scholar Back to article
Chang D, Saleh M, Gabriels J, et al. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin. J Am Coll Cardiol. 2020 Jun 16;75(23):2992–2993. doi: 10.1016/j.jacc.2020.04.032
Open DOI Search in Google Scholar Back to article
Mazzanti A, Briani M, Kukavica D, et al. Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19. Circulation. 2020 Aug 4;142(5):513–515. doi: 10.1161/CIRCULATIONAHA.120.048476
Open DOI Search in Google Scholar Back to article
Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Heart Rhythm. 2020 Sep;17(9):1472–1479. doi: 10.1016/j.hrthm.2020.05.008
Open DOI Search in Google Scholar Back to article
Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar;59(3):252–6. doi: 10.1136/thorax.2003.012658
Open DOI Search in Google Scholar Back to article
Kim UJ, Won EJ, Kee SJ, Jung SI, Jang HC. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome. Antivir Ther. 2016;21(5):455–9. doi: 10.3851/IMP3002
Open DOI Search in Google Scholar Back to article
Chaubey SK, Sinha AK, Phillips E, Russell DB, Falhammar H. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sex Health. 2009 Sep;6(3):254–7. doi: 10.1071/SH09005
Open DOI Search in Google Scholar Back to article
Beyls C, Martin N, Hermida A, Abou-Arab O, Mahjoub Y. Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia. Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008798. doi: 10.1161/CIRCEP.120.008798
Open DOI Search in Google Scholar Back to article
Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787–1799. doi: 10.1056/NEJMoa2001282
Open DOI Search in Google Scholar Back to article
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813–1826. doi: 10.1056/NEJMoa2007764
Open DOI Search in Google Scholar Back to article
Spinner CD, Gottlieb RL, Criner GJ, et al. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 Sep 15;324(11):1048–1057. doi: 10.1001/jama.2020.16349
Open DOI Search in Google Scholar Back to article
Gubitosa JC, Kakar P, Gerula C, et al. Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review. JACC Case Rep. 2020 Nov 18;2(14):2260–2264. doi: 10.1016/j.jaccas.2020.08.025
Open DOI Search in Google Scholar Back to article
Barkas F, Styla CP, Bechlioulis A, Milionis H, Liberopoulos E. Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review. J Cardiovasc Dev Dis. 2021 Feb 12;8(2):18. doi: 10.3390/jcdd8020018
Open DOI Search in Google Scholar Back to article
Gupta AK, Parker BM, Priyadarshi V, Parker J. Cardiac Adverse Events With Remdesivir in COVID-19 Infection. Cureus. 2020 Oct 24;12(10):e11132. doi: 10.7759/cureus.11132
Open DOI Search in Google Scholar Back to article
Touafchia A, Bagheri H, Carrié D, et al. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns. Clin Microbiol Infect. 2021 Feb 27;27(5):791.e5–791.e8. doi: 10.1016/j.cmi.2021.02.013
Open DOI Search in Google Scholar Back to article
Gupta S, Wang W, Hayek SS, et al. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021 Jan 1;181(1):41–51. doi: 10.1001/jamainternmed.2020.6252
Open DOI Search in Google Scholar Back to article
Salama C, Han J, Yau L, et al. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 Jan 7;384(1):20–30. doi: 10.1056/NEJMoa2030340
Open DOI Search in Google Scholar Back to article
Lazzerini PE, Acampa M, Capecchi PL, et al. Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation. Arthritis Care Res (Hoboken). 2015 Mar;67(3):332–9. doi: 10.1002/acr.22455
Open DOI Search in Google Scholar Back to article
Horby P, Lim WS, Emberson JR, et al. RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693–704. doi: 10.1056/NEJMoa2021436
Open DOI Search in Google Scholar Back to article
van der Hooft CS, Heeringa J, Brusselle GG, et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med. 2006 May 8;166(9):1016–20. doi: 10.1001/archinte.166.9.1016
Open DOI Search in Google Scholar Back to article
Liu Q, Kong AL, Chen R, et al. Propofol and arrhythmias: two sides of the coin. Acta Pharmacol Sin. 2011 Jun;32(6):817–23. doi: 10.1038/aps.2011.42
Open DOI Search in Google Scholar Back to article
Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012 Mar 21;307(11):1151–60. doi: 10.1001/jama.2012.304
Open DOI Search in Google Scholar Back to article
Kako H, Krishna SG, Sebastian R, Smith K, Tobias JD. Effect of dexmedetomidine on the QT interval in pediatric patients undergoing general anesthesia. J Anesth. 2015 Dec;29(6):862–7. doi: 10.1007/s00540-015-2056-2
Open DOI Search in Google Scholar Back to article
Zhou WJ, Liu M, Fan XP. Differences in efficacy and safety of midazolam vs. dexmedetomidine in critically ill patients: A meta-analysis of randomized controlled trial. Exp Ther Med. 2021 Feb;21(2):156. doi: 10.3892/etm.2020.9297
Open DOI Search in Google Scholar Back to article
Zareini B, Rajan D, El-Sheikh M, et al. Cardiac arrhythmias in patients hospitalized with COVID-19: The ACOVID study. Heart Rhythm O2. 2021 Mar 23;2(3):304–308. doi: 10.1016/j.hroo.2021.03.008
Open DOI Search in Google Scholar Back to article
Cho JH, Namazi A, Shelton R, et al. Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States. PLoS One. 2020 Dec 28;15(12):e0244533. doi: 10.1371/journal.pone.0244533
Open DOI Search in Google Scholar Back to article
Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Hearth Rhythm. 2020 Sep;17(9):1439–1444. doi: 10.1016/j.hrthm.2020.06.016
Open DOI Search in Google Scholar Back to article
Musikantow DR, Turagam MK, Sartori S, et al. Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza. JACC Clin Electrophysiol. 2021 Sep;7(9):1120–1130. doi: 10.1016/j.jacep.2021.02.009
Open DOI Search in Google Scholar Back to article
Ip RJ, Ali A, Baloch ZQ, et al. Atrial Fibrillation as a Predictor of Mortality in High Risk COVID-19 Patients: A Multicentre Study of 171 Patients. Heart Lung Circ. 2021 Aug;30(8):1151–1156. doi: 10.1016/j.hlc.2021.02.010
Open DOI Search in Google Scholar Back to article
Mountantonakis SE, Saleh M, Fishbein J, et al. Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection. Heart Rhythm. 2021 Apr;18(4):501–507. doi: 10.1016/j.hrthm.2021.01.018
Open DOI Search in Google Scholar Back to article
Yarmohammadi H, Morrow JP, Dizon J, et al. Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19. Am J Cardiol. 2021 May 15;147:52–57. doi: 10.1016/j.amjcard.2021.01.039
Open DOI Search in Google Scholar Back to article
Abrams MP, Coromilas EJ, Wan EY, Rubin GA, Garan H, Dizon JM. Malignant ventricular arrhythmias in patients with severe acute respiratory distress syndrome due to COVID-19 without significant structural heart disease. HeartRhythm Case Rep. 2020 Nov;6(11):858–862. doi: 10.1016/j.hrcr.2020.08.017
Open DOI Search in Google Scholar Back to article
Shao F, Xu S, Ma X, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020 Jun;151:18–23. doi: 10.1016/j.resuscitation.2020.04.005
Open DOI Search in Google Scholar Back to article
Chinitz JS, Goyal R, Harding M, et al. Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis? Pacing Clin Electrophysiol. 2020 Oct;43(10):1199–1204. doi: 10.1111/pace.14042
Open DOI Search in Google Scholar Back to article
Kumar S, Arcuri C, Chaudhuri S, et al. A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis. Clin Cardiol. 2021 Jun;44(6):857–862. doi: 10.1002/clc.23622
Open DOI Search in Google Scholar Back to article
Li Y, Liu T, Tse G, et al. Electrocardiograhic characteristics in patients with coronavirus infection: A single-center observational study. Ann Noninvasive Electrocardiol. 2020 Sep;25(6):e12805. doi: 10.1111/anec.12805
Open DOI Search in Google Scholar Back to article
Berman JP, Abrams MP, Kushnir A, et al. Cardiac electrophysiology consultative experience at the epicenter of the COVID-19 pandemic in the United States. Indian Pacing Electrophysiol J. Nov-Dec 2020;20(6):250–256. doi: 10.1016/j.ipej.2020.08.006
Open DOI Search in Google Scholar Back to article
Desai AD, Boursiquot BC, Melki L, Wan EY. Management of Arrhythmias Associated with COVID-19. Curr Cardiol Rep. 2020 Nov 24;23(1):2. doi: 10.1007/s11886-020-01434-7
Open DOI Search in Google Scholar Back to article
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020 Aug 25;95(8):e1060–e1070. doi: 10.1212/WNL.0000000000009937
Open DOI Search in Google Scholar Back to article
Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021 Jun;31(3):385–394. doi: 10.1007/s10286-021-00803-8
Open DOI Search in Google Scholar Back to article
Arano Llach J, Victor Bazan VBG, Gemma Llados GLL, et al. Inappropriate sinus tachycardia in post-covid-19 Syndrome. Europace. 2021 May;23(Suppl 3):euab116.114. doi: 10.1093/europace/euab116.114
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1039 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 73 - 82

Submitted on: Sep 17, 2021

Accepted on: Sep 17, 2021

Published on: Dec 15, 2021

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

© 2021 Summit Pandat, Zhihao Zhu, Stephanie Fuentes-Rojas, Paul Schurmann, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 17 (2021): Issue 5